Literature DB >> 17392373

Human immunodeficiency virus bearing a disrupted central DNA flap is pathogenic in vivo.

Matthew D Marsden1, Jerome A Zack.   

Abstract

The central DNA flap is an important component of lentiviral vectors, but its significance in the context of wild-type human immunodeficiency virus (HIV) is currently unclear. To address this issue, we have compared the in vitro infection kinetics of NL4-3 with those of a flap-deficient mutant and evaluated the in vivo growth characteristics of these viruses by using the SCID-hu mouse model of HIV infection. Flap-deficient virus was only modestly attenuated in vitro, as assessed by single-round and spreading infection assays, and exhibited levels of replication and pathogenesis close to those of the wild-type in vivo. Hence, an intact central flap is not essential for HIV replication.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392373      PMCID: PMC1900283          DOI: 10.1128/JVI.00203-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.

Authors:  R D Berkowitz; A B van't Wout; N A Kootstra; M E Moreno; V D Linquist-Stepps; C Bare; C A Stoddart; H Schuitemaker; J M McCune
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

2.  Mechanism of human immunodeficiency virus type 1 localization in CD4-negative thymocytes: differentiation from a CD4-positive precursor allows productive infection.

Authors:  S G Kitchen; C H Uittenbogaart; J A Zack
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

Review 3.  Retroviral infection of non-dividing cells: old and new perspectives.

Authors:  Masahiro Yamashita; Michael Emerman
Journal:  Virology       Date:  2006-01-05       Impact factor: 3.616

4.  Reduced viral load and lack of CD4 depletion in SCID-hu mice infected with Rev-independent clones of human immunodeficiency virus type 1.

Authors:  A Valentin; G Aldrovandi; A S Zolotukhin; S W Cole; J A Zack; G N Pavlakis; B K Felber
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

5.  The central DNA flap of the human immunodeficiency virus type 1 is important for viral replication.

Authors:  Jan De Rijck; Zeger Debyser
Journal:  Biochem Biophys Res Commun       Date:  2006-08-31       Impact factor: 3.575

6.  Preparation and maintenance of SCID-hu mice for HIV research.

Authors:  G C Bristol; L Y Gao; J A Zack
Journal:  Methods       Date:  1997-08       Impact factor: 3.608

7.  Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse.

Authors:  H Kaneshima; L Su; M L Bonyhadi; R I Connor; D D Ho; J M McCune
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

8.  Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice.

Authors:  G M Aldrovandi; J A Zack
Journal:  J Virol       Date:  1996-03       Impact factor: 5.103

9.  Regions of human immunodeficiency virus type 1 nef required for function in vivo.

Authors:  G M Aldrovandi; L Gao; G Bristol; J A Zack
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Growth of macrophage-tropic and primary human immunodeficiency virus type 1 (HIV-1) isolates in a unique CD4+ T-cell clone (PM1): failure to downregulate CD4 and to interfere with cell-line-tropic HIV-1.

Authors:  P Lusso; F Cocchi; C Balotta; P D Markham; A Louie; P Farci; R Pal; R C Gallo; M S Reitz
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

View more
  22 in total

1.  HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore.

Authors:  Nathalie J Arhel; Sylvie Souquere-Besse; Sandie Munier; Philippe Souque; Stéphanie Guadagnini; Sandra Rutherford; Marie-Christine Prévost; Terry D Allen; Pierre Charneau
Journal:  EMBO J       Date:  2007-06-07       Impact factor: 11.598

Review 2.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

3.  Analysis of the viral elements required in the nuclear import of HIV-1 DNA.

Authors:  Lise Rivière; Jean-Luc Darlix; Andrea Cimarelli
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

Review 4.  Human immunodeficiency virus reverse transcriptase: 25 years of research, drug discovery, and promise.

Authors:  Stuart F J Le Grice
Journal:  J Biol Chem       Date:  2012-10-05       Impact factor: 5.157

Review 5.  Retroviral reverse transcriptases.

Authors:  Alon Herschhorn; Amnon Hizi
Journal:  Cell Mol Life Sci       Date:  2010-04-01       Impact factor: 9.261

Review 6.  Studies of retroviral infection in humanized mice.

Authors:  Matthew D Marsden; Jerome A Zack
Journal:  Virology       Date:  2015-02-11       Impact factor: 3.616

7.  Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.

Authors:  Marisa S Briones; Charles W Dobard; Samson A Chow
Journal:  J Virol       Date:  2010-03-10       Impact factor: 5.103

8.  The HIV-1 passage from cytoplasm to nucleus: the process involving a complex exchange between the components of HIV-1 and cellular machinery to access nucleus and successful integration.

Authors:  Kallesh Danappa Jayappa; Zhujun Ao; Xiaojian Yao
Journal:  Int J Biochem Mol Biol       Date:  2012-02-25

9.  Single mutations in HIV integrase confer high-level resistance to raltegravir in primary human macrophages.

Authors:  Matthew D Marsden; Patricia Avancena; Christina M R Kitchen; Trish Hubbard; Jerome A Zack
Journal:  Antimicrob Agents Chemother       Date:  2011-05-31       Impact factor: 5.191

10.  HIV-1 exploits importin 7 to maximize nuclear import of its DNA genome.

Authors:  Lyubov Zaitseva; Peter Cherepanov; Lada Leyens; Sam J Wilson; Jane Rasaiyaah; Ariberto Fassati
Journal:  Retrovirology       Date:  2009-02-04       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.